Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Sun Pharma receives DCGI approval for Molxvir�� (Molnupiravir) in India ".
Press Release Dec 28 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Dec 15 2021
- Press Release Nov 11 2021
- Press Release Nov 02 2021
- Press Release Nov 01 2021
- Press Release Oct 28 2021
Later from Sun Pharmaceutical Industries
- Press Release Jan 18 2022
- Sun Pharmaceutical Industries: Dividend Updates
- Press Release Jan 27 2022
- Sun Pharma launches PrCEQUA, the first dry eye treatment with nanomicellar technology, in Canada
- Press Release Jan 31 2022
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries